Tag: Pediatric Hospital Bambino Gesù

Omalizumab (Xolair)

Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...

Patients reached full tolerance for 70.4% of the tested foods which were reintroduced to the patients’ diet without the need for OIT.